filmov
tv
Kidney Cancer Highlights from ESMO 2023
Показать описание
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2023.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
DFCI
Dana-Farber
cancer
ESMO
Рекомендации по теме
0:25:09
Kidney Cancer Highlights from ESMO 2022
0:20:40
Kidney Cancer Highlights from ESMO 2023
0:16:41
ESMO 2024 Kidney Cancer Highlights
0:00:55
Genitourinary cancer highlights at ESMO 2023
0:06:10
ESMO 2018: Dr. George Highlights Key Abstracts in Kidney and Prostate Cancers
0:03:49
ESMO highlights: genitourinary cancers
0:04:12
Kidney cancer at ESMO 2022: KEYNOTE-564 and PROSPER
0:02:40
ESMO Congress 2024 GU Round-Up: Kidney Cancer
0:01:27
Genitourinary cancer highlights at ESMO 2022
0:00:59
Updates in kidney cancer at ESMO 2022
0:28:31
Prostate Cancer Highlights from ESMO 2022
0:21:03
Bladder Cancer Highlights from ESMO 2022
0:16:16
2022 GU ASCO Kidney Cancer Highlights
0:01:38
Kidney Cancer Research at ESMO 2020: Toni Choueiri, MD
0:00:56
GU Summary for ESMO 2023 | Dr. Rana McKay | Oncology Brothers #oncology
0:00:55
Upcoming updates in GU cancers at ESMO 2022
0:01:44
Highlights in renal cell carcinoma from ASCO GU 2023 and what to look out for in the future
0:02:05
ESMO 2020 Highlights on nivolumab+cabozantinib as 1st line therapy for aRCC: The CheckMate 9ER study
0:06:31
Kidney cancer at ESMO 2024: CONTACT-03, TiNivo-2 and SUNNIFORECAST
0:09:57
How to select 1st line therapy for metastatic renal cell cancer?
0:02:56
#ESMO22 Highlights on cabozantinib with nivo and ipi for intermediate/poor risk adv. RCC: COSMIC-313
0:04:33
Adjuvant checkpoint blockade in high-risk urothelial and kidney cancer
0:06:50
ESMO 2022: Renal roundup
0:02:14
ASCO 2018 bladder and kidney cancer highlights